Refine by
Body Simulation Articles & Analysis
7 news found
CD Formulation's in vitro testing involves placing drug-loaded microspheres and microneedles in a specialized release medium. This medium simulates the conditions of the body, allowing for accurate measurements of drug release rates. ...
VeriSIM Life has developed a whole-body biosimulation platform driven by AI and machine learning (ML), that accurately predicts the clinical efficacy of new drugs before human trials. ...
The company's technology enables scientists to gather critical information on the body's immune functioning, which ultimately speeds up the scientific process and brings life-saving drugs to market faster and at a reduced cost. ...
TEL AVIV, Israel, June 17, 2021 /PRNewswire/ -- CytoReason, an AI company developing a computational disease model of the human body for clinical drug development, today announced the initiation of a project with French global biopharmaceutical company Sanofi, which will utilize its cell-centered models and deconvolution techniques to suggest mechanistic insights for each asthma ...
CytoReason's use of computational models of the human body has the potential to help Ferring accelerate drug discovery while reducing costs. Leveraging an extensive library of both public and proprietary molecular data, CytoReason's technology allows scientists to gain critical information on the body's functioning, and to address diseases such as IBD at the ...
These tests are conducted in vitro in order to simplify the comparison of simulated vertebral body subsidence induced by the intervertebral body fusion devices. ...
Other test environments such as a simulated body fluid, a saline drip or mist, distilled water, or other type of lubrication could also be used with adequate justification. ...